Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery

University of Wisconsin (UW)

Status and phase

Completed

Phase 2

Conditions

Post-operative Pain

Gynecologic Cancer

Treatments

Drug: Bupivicaine

Drug: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT01444924

SMPH\OBSTET & GYNECOL ONC (Other Identifier)

NCI-2011-03675 (Registry Identifier)

2011-0274 (Other Identifier)

CO11701 (Other Identifier)

A532820 (Other Identifier)

Details and patient eligibility

About

This study is a single-center, randomized, placebo-controlled, double-blind clinical trial. The purpose of this study is to evaluate the impact of pre-operative transverses abdominis plane (TAP) blocks on post-operative analgesia in patients undergoing robotic surgery for gynecologic cancers.

Enrollment

75 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients undergoing robotic-assisted surgery under the care of the Division of Gynecologic Oncology at UWHC.
Patients must be ≥18 years old.
Patients must be English speaking.
Patients must have the ability to understand visual and verbal pain scales.
ASA physical status 1-3.

Exclusion criteria

Known allergy to local anesthetics.
Immunocompromised.
Known history of opioid dependence, as available within the medical record and standard of care pre-operative work-up.
Known history of chronic pain disorders.
Pregnancy or lactation.
Patient is a prisoner or incarcerated.
Significant liver disease that would inhibit prescription of opioids.